Taiwan FDA registration a7ef4f922db43a58306d052c925a7f6c
"Bidi" Antibiotic Test Kit - Dichloropus Neo
TW: "必帝" 抗生素試驗套組 - 敵癆新邁
Taiwan·Risk Class 2·BECTON, DICKINSON AND COMPANY (BD)·Registered Dec 29, 2005 – Dec 29, 2025ExpiredRegistration details
- Analysis ID
- a7ef4f922db43a58306d052c925a7f6c
- Customs Code
- DHA00601579007
Company information
- Manufacturer
- BECTON, DICKINSON AND COMPANY (BD)
- Manufacturer Country
- United States
- Authorized Representative
- BECTON DICKINSON HOLDINGS PTE. LTD. TAIWAN BRANCH (SINGAPORE)
Product details
- Intended Use
- 測試 Mycobacterium tuberculosis 對pyrazinamide (PZA) 的耐受性試驗.
- Product Type (Level 1)
- C Immunology and microbiology
- Product Type (Level 2)
- C.1640 抗菌感受性試驗粉末
- Import Information
- import
Dates and status
- Registration Date
- Dec 29, 2005
- Expiry Date
- Dec 29, 2025
About this record
Access comprehensive regulatory information for "Bidi" Antibiotic Test Kit - Dichloropus Neo in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number a7ef4f922db43a58306d052c925a7f6c and manufactured by BECTON, DICKINSON AND COMPANY (BD). The authorized representative in Taiwan is BECTON DICKINSON HOLDINGS PTE. LTD. TAIWAN BRANCH (SINGAPORE).
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Free DatabasePowered by Pure Global AI89,000+ Devices